Sat.Jul 31, 2021

article thumbnail

Even on social media “listen to the doctor”

World of DTC Marketing

SUMMARY : People are anxious because of the resurgence of COVID. Unfortunately, there is a lot of false and bad information online. To get accurate information, follow one of the many physicians online. They can provide answers based on science and their experience. The amount of critical health information online is an enormous problem. The media still hasn’t, for example, differentiated between testing positive for COVID and getting sick from COVID.

Doctors 253
article thumbnail

In the absence of genetic variation, asexual invasive species find new methods of adapting to their environment

Scienmag

Research from Wellesley College shows that despite being a clonal insect species, weevils use gene regulation to adapt to new food sources and pass down epigenetic changes to future generations Without the benefits of evolutionary genetic variation that accompany meiotic reproduction, how does an asexual invasive species adapt over time to a new environment to […].

Genetics 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT

Drug Patent Watch

Annual Drug Patent Expirations for SPY+AGENT+GREEN+KIT Spy Agent Green Kit is a drug marketed by Novadaq Tech and is included in one NDA. It is available from one supplier. There…. The post New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

BMS claims first EU okay for adjuvant oesophageal cancer immunotherapy

pharmaphorum

Bristol-Myers Squibb is in a battle with Merck & Co for position in the upper gastrointestinal cancer immunotherapy market, and has just reinforced its position with an EU approval in the post-surgery (adjuvant) setting. The European Commission has approved Opdivo (nivolumab) as the first-ever adjuvant immunotherapy for patients with oesophageal or gastroesophageal junction (GEJ) cancer, who have had surgery to remove the tumour after chemoradiotherapy to reduce its size, but still have some

Sales 52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

New patent expiration for Kastle Theraps drug KYNAMRO

Drug Patent Watch

Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are four patents protecting this drug. This drug…. The post New patent expiration for Kastle Theraps drug KYNAMRO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

What Questions A Clinical Research Coordinator Can Ask The Job Interviewer During Interview

Clinical Trial Gurus

With so much emphasis understandably being placed on interview questions one may be asked during a clinical research coordinator job interview, I have never heard anyone discuss what questions the applicant should ask the interviewer. In this video I attempt to do exactly that.

More Trending

article thumbnail

Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium

BioTech 365

Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium PRESS RELEASE 31 July 2021, 18:00 CET Fire Incident at Biocartis Warehouse … Continue reading →

40
article thumbnail

Drugs facing the most patent expirations this year

Drug Patent Watch

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…. The post Drugs facing the most patent expirations this year appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52